Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 68382-034

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 68382-034). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Venlafaxine Hydrochloride Extended-release Capsules, Usp (E5d724aa Bc22 4503 B0e0 87b3b1d4a77e 01)

This is a drug interaction table that provides information on how Ethanol, Diazepam, Cimetidine, Ketoconazole, Indinavir, Metoprolol, Imipramine, and Lithium interact with CYP2D6 EM's and PM's. The table suggests the recommended PK fold change and 90% C, Cmax, AUC for these drugs. It also provides recommendations on how to use and adjust the dose for these drugs in certain patients depending on their medical conditions.*

FDA Label Image

Venlafaxine Hydrochloride Extended-release Capsules, Usp (E5d724aa Bc22 4503 B0e0 87b3b1d4a77e 02)

This appears to be a table showing the interactions and effects of various drugs, including ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, and lithium. The table also shows PKFold change and 90% C Recommendation for each drug, as well as Cmax and Auc values and any dose adjustments or restrictions that should be made when using certain drugs together. There are also references to active moieties and a footnote regarding a Cmax value.*

FDA Label Image

Venlafaxine Hydrochloride Extended-release Capsules, Usp (E5d724aa Bc22 4503 B0e0 87b3b1d4a77e 03)

This is a report on the recommended dosing adjustments for the drug, venlafaxine, in patients with various medical conditions such as hepatic impairment, renal impairment, and age above 80 years. The CYP2D8 polymorphism is also taken into consideration. The recommendation suggests a reduction in dosage ranging from 25% to 50% or an individualization of dosing may be necessary depending on each patient's condition. The report also provides fold change and 90% CI values.*

FDA Label Image

Venlafaxine Hydrochloride Extended-release Capsules, Usp (E5d724aa Bc22 4503 B0e0 87b3b1d4a77e 04)

FDA Label Image

Venlafaxine Hydrochloride Extended-release Capsules, Usp (E5d724aa Bc22 4503 B0e0 87b3b1d4a77e 05)

This is a description of Venlafaxine Hydrochloride Extended-Release Capsules, USP with NDC 68382-034-10. It is a prescription medication that comes in a bottle of 1,000 capsules and is for use under a doctor’s prescription only. The usual dosage is found in the package insert. It should be stored at a temperature between 20°C to 25°C, and dispensed in a light-resistant container. The medication guide is available online or by calling the number provided. The manufacturer is Cadia Healthcare L. in Ahmedabad, India, and it is distributed by Zydus Pharmaceuticals (USA) Inc. in Pennington, NJ.*

FDA Label Image

Venlafaxine Hydrochloride Extended-release Capsules, Usp (E5d724aa Bc22 4503 B0e0 87b3b1d4a77e 06)

Venlafaxine Hydrochloride Extended-Release Capsules, USP are a prescription medication containing 75mg of Venlafaxine Hydrochloride used for the treatment of depression and anxiety disorders. This package contains 1000 capsules and should be stored at controlled room temperature. Patients are advised to read the medication guide provided separately for complete prescribing information. The capsules should be kept away from children and dispensed in a light container. This medication is produced by Cadila Healthcare L in Ahmedabad, India, and distributed by Zydus Pharmaceuticals (USA) Inc. in Pennington, NJ.*

FDA Label Image

Venlafaxine Hydrochloride Extended-release Capsules, Usp (E5d724aa Bc22 4503 B0e0 87b3b1d4a77e 07)

This is a prescription drug named Venlafaxine Hydrochloride Extended-Release Capsules with a concentration of 150mg. The package contains 1,000 capsules and should be stored between 20-25°C. The usual dosage is not provided, but it is mentioned that the package insert contains complete prescribing information. The drug should be kept away from children and a medication guide is available on the website provided or by calling the given number. The drug is made in India by Cadila Healthcare L and is distributed in the USA by Zydus Pharmaceuticals.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.